SCHEMBL4907589

SCHEMBL4907589

O=C(O)c1cccc(Nc2ncc(Cl)cc2[N+](=O)[O-])c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.57
MAPT P10636 3/20 0.56
AKR1C4 P17516 4/20 0.53
AKR1C3 P42330 4/20 0.53
AKR1C2 P52895 4/20 0.53
AKR1C1 Q04828 4/20 0.53
AR P10275 1/20 0.53
MAPK1 P28482 2/20 0.53
POLB P06746 1/20 0.53
KMT2A Q03164 5/20 0.53
MEN1 O00255 4/20 0.52
MYC P01106 1/20 0.52
JAK2 O60674 1/20 0.51
AKR1B1 P15121 2/20 0.50
AKR1B10 O60218 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
ALDH1A1 P00352 1/20 0.49
ABCG2 Q9UNQ0 1/20 0.48
AURKA O14965 1/20 0.48
GSK3A P49840 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6798177 0.81 KMT2A (0.65) TDP1MAPTAKR1C4AKR1C3AKR1C2
SCHEMBL4902552 0.80 RAB9A (0.51) MAPTAKR1C3MAPK1POLBKMT2A
SCHEMBL11429763 0.77 MAPT (0.59) TDP1MAPTMAPK1POLBKMT2A
SCHEMBL29565312 0.76 MAPT (0.78) TDP1MAPTAKR1C4AKR1C3AKR1C2
SCHEMBL30776873 0.76 MAPT (0.78) TDP1MAPTAKR1C4AKR1C3AKR1C2
SCHEMBL23675211 0.76 MAPT (0.78) TDP1MAPTAKR1C4AKR1C3AKR1C2
SCHEMBL7020138 0.76 AHR (0.51) TDP1MAPTMAPK1POLBJAK2
SCHEMBL29141097 0.74 MAPT (0.69) TDP1MAPTAKR1C4AKR1C3AKR1C2
SCHEMBL5416188 0.74 GSK3B (0.65) MAPTAKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL2365741 0.73 MEN1 (0.62) MAPTMAPK1KMT2AMEN1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors GLAXO GROUP LIMITED (GB) 2008-11-27 US disclosed
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors GLAXO GROUP LIMITED (GB) 2008-11-27 US disclosed
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors GLAXO GROUP LIMITED (GB) 2008-11-27 US disclosed
WO-2007067875-A2 PYRIDINYL SULFONAMIDE MODULATORS OF CHEMOKINE RECEPTORS GLAXO GROUP LIMTED (GB) 2007-06-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors CCR2, CCR1, CCRL2 TDP1 4723/4885MAPT 3959/4885AKR1C4 1117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.